Edward J. Dulac III
Overview
Edward J. Dulac III received an average of $6M in total compensation, including $281K in salary, at Fate Therapeutics between 2020 and 2021.
Source: SEC filings on April 25, 2022 and April 21, 2021.
Related executives
We found ten more executives who work or worked at Fate Therapeutics.
J Wolchko
Fate Therapeutics
Chief Executive Officer
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
Cindy Tahl
Fate Therapeutics
General Counsel
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
Daniel Shoemaker
Fate Therapeutics
Chief Scientific Officer
Christopher Storgard
Fate Therapeutics
Chief Medical Officer
Stewart Abbot
Fate Therapeutics